HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Need to evaluate the cost effectiveness of early diagnosis and treatment of osteopenia and osteoporosis in the setting of HIV and highly active antiretroviral therapy.

AuthorsRoberto Manfredi
JournalAIDS patient care and STDs (AIDS Patient Care STDS) Vol. 20 Issue 10 Pg. 665-7 (Oct 2006) ISSN: 1087-2914 [Print] United States
PMID17052136 (Publication Type: Letter)
Topics
  • Antiretroviral Therapy, Highly Active (adverse effects)
  • Bone Diseases, Metabolic (diagnosis, drug therapy, economics)
  • Cost-Benefit Analysis
  • Female
  • HIV Infections (complications, drug therapy)
  • Humans
  • Male
  • Osteoporosis (diagnosis, drug therapy, economics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: